Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,384 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05127148Recruiting
Real-world study of pediatric-like treatment for Ph-negative ALL
This study follows how well a “pediatric-style” treatment plan works in teens and young adults with Ph-negative acute lymphoblastic leukemia (ALL) in real-world care. It mainly aims to understand outcomes and safety for patients who fit the specific leukemia and health criteria.
Paraná, Entre Ríos ProvinceAges 18–40 - NCT05128890Recruiting
People who had prior pancreatic or liver surgery
This study looks back at people who previously had surgery to remove part of the pancreas or liver at a specific hospital. It aims to compare different resection (removal) techniques and how patients did afterward.
Dallas, TexasAges 18 years+ - NCT05129605Recruiting
Prostate cancer genetic risk screening study for men
This study looks at your personal and family risk for prostate cancer and helps decide who should have extra screening like MRI. It may help you find cancer earlier if you are at higher genetic risk.
Boston, MassachusettsAges 35–74 - NCT05131321Recruiting
Testing a frailty-focused plan for serious ankle fractures
This trial studies how best to manage serious ankle or tibia-pilon fractures in older adults who may be frail or have other major health problems. The goal is to improve care decisions and outcomes after injury, especially in people more likely to have complications.
London, OntarioAges 40 years+ - NCT05135403Recruiting
Registry study for the ASSURE wearable heart defibrillator
This study collects information from adults who have been prescribed the ASSURE wearable defibrillator. The goal is to understand how the device performs in real-world patients after it is approved.
Seattle, WashingtonAges 18 years+ - NCT05140434Recruiting
Check whether exercise heart tests help diagnose artery blockage
This study looks at whether an “exercise heart test” can better diagnose blockage in the heart’s coronary arteries. Participants may also have a heart scan or imaging test for comparison, within a short time window.
Corbeil-Essonnes, FranceAges 18 years+ - NCT05141916Recruiting
Testing the best way to evaluate suspected bile duct stones
This trial studies how doctors should best check and manage people with suspected bile duct stones. It may help improve the accuracy and safety of next-step testing and treatment.
Calgary, AlbertaAges 18 years+ - NCT05149742Recruiting
Study of hearing loss and thinking skills in midlife adults
This study looks at how severe hearing loss affects thinking and memory in adults aged 45–64. Researchers will compare people with significant hearing loss to people with normal hearing who are similar in age, sex, and education.
ParisAges 45–64 - NCT05155189RecruitingPhase 1
Armored CAR-T treatment for advanced liver cancer
This Phase 1 trial tests the safety and early signs of effectiveness of an “armored” CAR-T cell therapy (C-CAR031) for advanced hepatocellular carcinoma (liver cancer). It may help by teaching the body’s immune cells to better recognize and attack the cancer.
Hangzhou, ZhejiangAges 18–75 - NCT05157113RecruitingPhase 4
After cataract surgery, a drop-free medicine plan
This trial studies whether a “drop-free” medication plan after cataract surgery works well and is practical for people receiving care at a county hospital. It may help reduce the need for multiple eye drops after surgery while still protecting the eye as it heals.
San Francisco, CaliforniaAges 18 years+ - NCT05157685RecruitingPhase 3
Azithromycin for chronic pus-filled sinus inflammation
This Phase 3 trial tests whether the antibiotic azithromycin can improve chronic sinus problems where there is persistent pus and swelling. It’s for adults who have not improved despite at least two prior antibiotics.
BordeauxAges 18–70 - NCT05166694Recruiting
Personalized testing to check drug interactions and gene effects
This study uses personalized information to help understand how your current medicines interact with each other and with your genes. It may help your care team choose safer, more effective medication plans for you.
Chicago, IllinoisAges 18 years+ - NCT05166343RecruitingPhase 2/Phase 3
Testing a shot of epinephrine during out-of-hospital CPR
This trial studies whether giving a medicine shot (epinephrine) into the muscle helps children who have a cardiac arrest outside the hospital. It’s meant for emergency situations where CPR is started right away by trained responders.
London, OntarioAges 1 day–17 years - NCT05168566RecruitingPhase 2
Sutetinib for lung cancer with a specific EGFR change
This Phase 2 study tests sutetinib capsules in people with advanced (locally advanced or metastatic) non-small cell lung cancer. It’s for tumors that have a specific, uncommon EGFR mutation, and aims to see how well the drug can control the cancer with limited prior chemotherapy.
Glendale, CaliforniaAges 18 years+ - NCT05171478Recruiting
Test imaging on small lung biopsy samples during bronchoscopy
This study uses a special eye-like scanning camera (full-field optical coherence tomography) to look at tiny lung tissue samples taken during routine bronchoscopy. It may help doctors learn more from small biopsies used to diagnose or stage lung problems.
Baltimore, MarylandAges 18 years+ - NCT05171894RecruitingPhase 2
Test of lower light dose for port-wine birthmarks
This Phase 2 study tests whether using a lower light dose during a treatment called Hemoporfin PDT can safely shrink port-wine birthmarks (PWB). It aims to find a dose that works well while causing fewer side effects.
Irvine, CaliforniaAges 18–75 - NCT05178966Recruiting
One-day therapy education to lessen bipolar caregiver stress
This study tests whether a one-day session that teaches patients and caregivers about bipolar disorder can reduce the caregiver’s burden (stress and workload). You may be eligible if you’re an adult with bipolar disorder and have a regular caregiver willing to join the session.
MontpellierAges 18 years+ - NCT05181735RecruitingPhase 1/Phase 2
Testing luspatercept for low-risk MDS with low hemoglobin
This Phase 1/2 study tests luspatercept combined with another approach in people with low-risk myelodysplastic syndrome (MDS) who are not responding to or cannot use ESA (a common anemia treatment). It may help improve anemia (low hemoglobin), reduce transfusions, and control the disease if you fit the specific criteria.
AmiensAges 18 years+ - NCT05191264Recruiting
Screws plus cement to treat bone metastases
This trial looks at a treatment that uses metal screws along with cement to stabilize and treat weakening spots in bones caused by metastases. It’s meant for people who have already received this type of procedure and want to be included in the study.
Saint-EtienneAges 18 years+ - NCT05191706RecruitingPhase 4
Check how safe DEXYCU is after childhood cataract surgery
This trial studies whether DEXYCU is safe to use to reduce eye inflammation after cataract surgery in children. It aims to see if the medicine’s side effects are acceptable and whether it helps during normal recovery.
Huntington Beach, CaliforniaAges Up to 3 years - NCT05193591Recruiting
Test antibodies in active lupus with kidney involvement
This study looks at specific immune antibodies (against C1s, HMGB1, and C1q) in adults with systemic lupus erythematosus, especially when lupus is actively affecting the kidneys. It may help researchers better understand what is driving active lupus and who could benefit from future treatments.
GrenobleAges 18 years+ - NCT05197764Recruiting
Track muscle growth in young children with spastic cerebral palsy
This study looks at how the muscles in the body grow in infants and young children with spastic cerebral palsy (a type of movement difference). It may help doctors better understand normal growth patterns and how care choices affect muscle development.
Leuven, Vlaams-BrabantAges 6 months–9 years - NCT05199376Recruiting
Cryotherapy treatment for painful, hard-to-remove NF1 tumors
This trial tests whether freezing treatment done through the skin (cryotherapy) can reduce pain and discomfort from certain non-cancer NF1 tumors that can’t be safely removed. You may be able to join if you’re an adult with NF1, a painful or bothersome benign lesion, and can safely undergo procedures like MRI.
LyonAges 18 years+ - NCT05199688RecruitingPhase 3
Satralizumab for children with AQP4-positive NMOSD attacks
This trial studies satralizumab in children ages 2 to 11 with a specific type of NMOSD caused by AQP4 antibodies. It aims to see how well the medicine prevents attacks and is safe over time.
Denver, ColoradoAges 2–11
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,384 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.